Image
15.11.2021
The Key to raising awareness for diabetes
Despite all the challenges of the last 18 months, The Key charity shop in Larne has exceeded all expectat...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more